A Year of Continued Growth and Success
Authors: W. K. A. Yung
Journal: Neuro-Oncology (2011)

2011 was another strong year for Neuro-Oncology. The journal is projected to receive approximately 658 papers by the end of 2011, a substantial increase from 582 in 2010, when the journal began to be published monthly, and 576 in 2009. Free online access to Neuro-Oncology was added to the membership benefits of the European Association of Neuro-Oncology, further increasing the journal's distribution and exposure, and a mobile version of our website became available.

We are also pleased to report that our quality standard has remained high despite our continued growth, as reflected by our 2010 impact factor number of 5.483. This figure, released annually by Thomson Scientific in the Journal Citation Reports, is substantially higher than the 4.984 reported in 2009 and demonstrates an improved citation rate during a period of transition and flux for the journal. Neuro-Oncology is now ranked 24th of 185 oncology journals and 15th of 185 clinical neurology journals.

Starting with volume 14, Neuro-Oncology will begin requiring structured abstracts (organized into Background, Methods, Results, and Conclusions sections) for all submitted manuscripts. We believe that this will make papers easier to review and index. We ask that all authors please keep this new format in mind when submitting their articles for consideration.​consideration.



Fig. 1.

Neuro-Oncology's impact factors since 2002. The journal switched from quarterly publication to bimonthly in 2008 and to monthly in 2010. The 2010 impact factor of 5.483 reflects papers published in 2008 and 2009.



Neuro-Oncology is indebted to the tireless members of our editorial board (whose names appear in every issue of the journal) and other peer reviewers for helping us succeed (listed below are those reviewers who had agreed to conduct manuscript reviews as of October 31). We also thank our authors and readers for their ongoing valuable contributions to the journal.

Till Acker

Manish Aghi

Francis Ali-Osman

Jeffrey Allen, MD

James Michael Angelastro

Terri S. Armstrong

Joachim M. Baehring

Ute Bartels

Michael Brada

Cameron W. Brennan

Dan Cahill

Steven L. Carroll

Craig Castellino

Marc C. Chamberlain

Susan Chi

Jennifer Clarke

Elizabeth Brooks Claus

Charles Cobbs

Kenneth J. Cohen

Courtney Crane

Faith G. Davis

Linda Douw

Joan Engebretson

Bradley Erickson

Graziella Filippini

John C. Flickinger

Nicholas Foreman

Takamitsu Fujimaki

Mitsugu Fujita

Caterina Giannini

Richard J. Gilbertson

Kristine Glunde

Stewart Goldman

Candelaria Gomez-Manzano

Vidya Gopalakrishnan

Morris Groves

Nalin Gupta

Marlan Hansen

Christian Hartmann

Cynthia Hawkins

John W. Henson

Christal Herold-Mende

Ulrich Herrlinger

Kenneth Hess

Yuichi Hirose

Khe Hoang-Xuan

Leland Hu

Suyun Huang

Peter D. Inskip

Andreas H. Jacobs

Randy Jensen

Tao Jiang

Jeno Viktor Julow

Bernd Kaina

Daniel Kamei

Yukinari Kato

Timothy Kaufmann

Santosh Kesari

Helmut Kettennmann

Peter Krauseneck

Ashok Kumar

Lawrence Lamb

Heiner Langermann

Florence Lefranc

Maciej Lesniak

Maria Lopes

Lorenzo Magrassi

James M. Markert

Warren Mason

Masao Matsutani

Ian E. McCutcheon

Roger McLendon

Alex McMillan

Kazuhiko Mishima

Sabine Mueller

Do-Hyun Nam

Gila Neta

Edward A. Neuwelt

Theo Nicolaides

Andrew Norden

Terry Parker

Andrew T. Parsa

Vinay K. Puduvalli

Zvi Ram

Jaap C. Reijneveld

Sabrina Ronen

Joshua B. Rubin

Raymond Sawaya

Davide Schiffer

S. Clifford Schold, Jr.

Walter Stummer

Ghazaleh Tabatabai

Shingo Takano

Christina Tsien

Takaaki Yanagisawa

Seiichi Yoshida

Wei Zhang

The editorial office apologizes for any inadvertent omissions.